Detect is a health technology company focused on developing a molecular Covid-19 test that combines the accuracy of PCR lab tests with the convenience of rapid results. The test delivers results within one hour and is designed for user comfort, requiring only a quick, shallow nostril swab. The company's proprietary chemistry, embedded in the Detect Cap, ensures robustness against new SARS-CoV-2 variants and adaptability to future pathogens. Detect's target market includes healthcare providers, businesses, and individuals seeking reliable and fast Covid-19 testing solutions. The business model revolves around selling the Detect Hub and Test Kit, generating revenue through direct sales and potential subscription services for regular testing needs. Founded by Dr. Jonathan Rothberg, a renowned scientist with a history of successful ventures in health technology, Detect leverages advanced molecular techniques to provide high-accuracy testing.

Keywords: molecular test, Covid-19, PCR accuracy, rapid results, nostril swab, SARS-CoV-2, proprietary chemistry, healthcare, diagnostics, Jonathan Rothberg.